Medical cannabis is not a first-line treatment. Our specialist doctors consider it only for patients who have already tried licensed treatment options without adequate relief. Eligibility is always assessed individually — the conditions below are examples of what our clinicians commonly review, not a guarantee of prescribing.
Persistent pain that has not responded adequately to standard licensed pain management.
Our specialists review pain history, previous treatments tried, and current management plans before considering whether a cannabis-based medicinal product may be clinically appropriate alongside your existing care.
Muscle stiffness and spasms associated with multiple sclerosis.
NICE guidance recognises cannabis-based medicinal products as an option for MS-related spasticity where licensed treatments have not provided sufficient symptom control.
Nausea and vomiting linked to cancer treatment that has not settled with standard anti-sickness medication.
Assessment includes your current oncology treatment plan and anti-emetic history, in coordination with your existing care team where appropriate.
Seizure disorders that have not responded to at least two licensed anti-epileptic medications.
These cases require detailed neurological history and are typically reviewed alongside a patient’s existing neurology consultant.
Anxiety symptoms that have not adequately improved with licensed medication and/or therapy.
Our clinicians review prior treatment history, including psychological therapies and licensed medication, as part of a full mental health assessment.
Widespread musculoskeletal pain and fatigue not sufficiently managed with standard treatment.
Given the complexity of fibromyalgia, assessment covers pain history, sleep, and prior management strategies in detail.
Inflammatory bowel symptoms where licensed treatments have not achieved adequate control.
Reviewed alongside your gastroenterology history, current medications, and disease activity.
PTSD symptoms not adequately managed by licensed treatment or trauma-focused therapy.
Assessment includes a full mental health history and current support in place, conducted with appropriate care and confidentiality.
Being diagnosed with a condition listed above does not guarantee a prescription. UK guidelines require that cannabis-based medicinal products only be considered after licensed treatment options have been tried and have not provided adequate relief. A specialist doctor will review your full medical history before making any clinical decision. If your condition isn’t listed here, you may still be eligible — we assess every enquiry individually.
Complete our short online form and a specialist clinician will review your case.
Check Your Eligibility